Vein of Galen Malformations.

Arteriovenous malformation Congenital vascular malformation Embolization Transarterial Transvenous Vein of Galen malformation

Journal

Neurosurgery clinics of North America
ISSN: 1558-1349
Titre abrégé: Neurosurg Clin N Am
Pays: United States
ID NLM: 9008004

Informations de publication

Date de publication:
Jul 2024
Historique:
medline: 24 5 2024
pubmed: 24 5 2024
entrez: 23 5 2024
Statut: ppublish

Résumé

Significant efforts have been made over the last few decades to improve the diagnosis and management of patients with vein of Galen malformations (VOGMs). The mainstays of treatment remain focused on primary endovascular management by staged transarterial embolizations with adjunctive use of transvenous embolization, medical therapy, and neurosurgical intervention for symptom control in select patients. Innovation in endovascular technology and techniques as well as promising new genomic research elucidating potential therapeutic targets hold significant promise for the future of VOGM treatment.

Identifiants

pubmed: 38782529
pii: S1042-3680(24)00019-6
doi: 10.1016/j.nec.2024.02.008
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

363-374

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Auteurs

Alex Devarajan (A)

Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Daryl Goldman (D)

Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Tomoyoshi Shigematsu (T)

Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Alejandro Berenstein (A)

Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Johanna T Fifi (JT)

Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: Johanna.fifi@mountsinai.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH